French biotech Sensorion does not expect any impact to its liquidity from SVB's closure
PARIS, March 13 (Reuters) - French biotech company
Sensorion ALSEN.PA said on Monday that it did not expect any
impact to its liquidity or operations as a result of the closure
of Silicon Valley Bank SIVB.O .
"Sensorion does not expect any impact to its liquidity
position or its ongoing operations as a result of the SVB
closure," it said in a statement.
(Reporting by Sudip Kar-Gupta)
((sudip.kargupta@thomsonreuters.com;))
Recent news on Sensorion SA
See all newsEurope Research Roundup: Glencore, Hydro, SIG Group
Europe Research Roundup: Ashmore, Chemring Group, Qinetiq Group
Brief: Sensorion Says CEO Nawal Ouzren To Step Down
Analysis: Trump health policy uncertainty sends biotech sector into deeper slump
Brief: Sensorion Announces EUR 15 Mln Financing, Extending Cash Runway Until End 2025